Table I Index
Table of Contents
Table I - 43 Kosciusko Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 253 | 328.0 | 128 | 367.1 | 125 | 302.9 |
Oral cavity and pharynx | 10 | 13.7** | 9 | 26.4** | * | # |
Lip | * | # | * | # | * | # |
Tongue | * | # | * | # | * | # |
Major salivary glands | * | # | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | * | # | * | # | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 37 | 46.7 | 23 | 65.3 | 14 | 34.5** |
Esophagus | * | # | * | # | * | # |
Stomach | * | # | * | # | * | # |
Small intestine | * | # | * | # | * | # |
Colon excluding rectum | 25 | 30.7 | 18 | 49.8** | 7 | 17.0** |
Rectum and rectosigmoid | 5 | 6.1** | * | # | * | # |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | * | # | * | # | * | # |
Gallbladder | * | # | * | # | * | # |
Other biliary | * | # | * | # | * | # |
Pancreas | * | # | * | # | * | # |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 52 | 68.4 | 28 | 80.1 | 24 | 58.3 |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | 5 | 6.8** | * | # | * | # |
Lung and bronchus | 47 | 61.6 | 24 | 68.3 | 23 | 56.2 |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | * | # | * | # | * | # |
Skin (excluding basal and squamous) | * | # | * | # | * | # |
Melanoma of the skin | * | # | * | # | * | # |
Other non-epithelial skin cancers | * | # | * | # | * | # |
Breast | 38 | 47.6 | * | # | 37 | 88.0 |
Female genital system | 29 | 36.3 | -- | -- | 29 | 68.4 |
Cervix uteri | * | # | -- | -- | * | # |
Corpus uteri | 17 | 22.3** | -- | -- | 17 | 42.4** |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | 10 | 11.8** | -- | -- | 10 | 21.7** |
Vagina | * | # | -- | -- | * | # |
Vulva | * | # | -- | -- | * | # |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 35 | 45.7 | 35 | 99.3 | -- | -- |
Prostate gland | 33 | 43.2 | 33 | 94.2 | -- | -- |
Testis | * | # | * | # | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 13 | 17.7** | 10 | 29.3** | * | # |
Urinary bladder | 11 | 14.9** | 9 | 26.0** | * | # |
Kidney and renal pelvis | * | # | * | # | * | # |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | 5 | 6.4** | * | # | * | # |
Brain | * | # | * | # | * | # |
Other nervous system | * | # | * | # | * | # |
Endocrine system | * | # | * | # | * | # |
Thyroid gland | * | # | * | # | * | # |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 7 | 9.9** | * | # | * | # |
Hodgkin’s disease | * | # | * | # | * | # |
Non-Hodgkin’s lymphoma | * | # | * | # | * | # |
Multiple myeloma | * | # | * | # | * | # |
Leukemia | 13 | 16.4** | 9 | 25.4** | * | # |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | * | # | * | # | * | # |
Acute myeloid | * | # | * | # | * | # |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | * | # | * | # | * | # |
Other, ill-defined and unknown sites | * | # | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |